CN Patent

CN101062084A — 一种抗肝炎的药物组合物

Assigned to Jiangyin Tianjiang Pharmaceutical Co Ltd · Expires 2007-10-31 · 19y expired

What this patent protects

本发明属于医药技术领域，公开了一种新的用于治疗肝脏疾病的药物组合物及其制备方法，该药物组合物主要由甘草酸或其药学上可接受的盐、硫普罗宁、苦参素、水飞蓟宾或其衍生物或水飞蓟素中的一种或几种和红景天或红景天多糖制成任一药学上可接受的剂型，优选注射剂和口服制剂。该药物组合物对于治疗肝炎、肝损伤、肝纤维化等疾病，产生了意想不到的效果，具有广泛的应用前景。

USPTO Abstract

本发明属于医药技术领域，公开了一种新的用于治疗肝脏疾病的药物组合物及其制备方法，该药物组合物主要由甘草酸或其药学上可接受的盐、硫普罗宁、苦参素、水飞蓟宾或其衍生物或水飞蓟素中的一种或几种和红景天或红景天多糖制成任一药学上可接受的剂型，优选注射剂和口服制剂。该药物组合物对于治疗肝炎、肝损伤、肝纤维化等疾病，产生了意想不到的效果，具有广泛的应用前景。

Drugs covered by this patent

Patent Metadata

Patent number: CN101062084A
Jurisdiction: CN
Classification: —
Expires: 2007-10-31
Drug substance claim: No
Drug product claim: No
Assignee: Jiangyin Tianjiang Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.